The immunoproteasome : a novel drug target for autoimmune diseases

Cite This

Files in this item

Files Size Format View

There are no files associated with this item.

BASLER, Michael, Sarah MUNDT, Annegret BITZER, Christian SCHMIDT, Marcus GROETTRUP, 2015. The immunoproteasome : a novel drug target for autoimmune diseases. In: Clinical and Experimental Rheumatology. 33(4, Suppl. 92), pp. S74-S79. ISSN 1593-098X

@article{Basler2015immun-33213, title={The immunoproteasome : a novel drug target for autoimmune diseases}, year={2015}, number={4, Suppl. 92}, volume={33}, issn={1593-098X}, journal={Clinical and Experimental Rheumatology}, pages={S74--S79}, author={Basler, Michael and Mundt, Sarah and Bitzer, Annegret and Schmidt, Christian and Groettrup, Marcus} }

<rdf:RDF xmlns:dcterms="http://purl.org/dc/terms/" xmlns:dc="http://purl.org/dc/elements/1.1/" xmlns:rdf="http://www.w3.org/1999/02/22-rdf-syntax-ns#" xmlns:bibo="http://purl.org/ontology/bibo/" xmlns:dspace="http://digital-repositories.org/ontologies/dspace/0.1.0#" xmlns:foaf="http://xmlns.com/foaf/0.1/" xmlns:void="http://rdfs.org/ns/void#" xmlns:xsd="http://www.w3.org/2001/XMLSchema#" > <rdf:Description rdf:about="https://kops.uni-konstanz.de/rdf/resource/123456789/33213"> <bibo:uri rdf:resource="https://kops.uni-konstanz.de/handle/123456789/33213"/> <dc:creator>Bitzer, Annegret</dc:creator> <dc:contributor>Basler, Michael</dc:contributor> <dcterms:issued>2015</dcterms:issued> <dc:creator>Groettrup, Marcus</dc:creator> <dcterms:abstract xml:lang="eng">The immunoproteasome, a special class of the proteasome, is mainly expressed in cells of haematopoietic origin. Additionally, during inflammation, the immunoproteasome is induced by IFN-γ or TNF-α. In recent years it became apparent that the immunoproteasome has important functions other than processing proteins for MHC class I restricted presentation. The immunoproteasome plays a critical role in T cell expansion, cytokine production, and T helper cell differentiation. Inhibition of the immunoproteasome ameliorated disease symptoms in different animal models for autoimmune diseases. Hence, the unique role for LMP7 in controlling pathogenic immune responses provides a therapeutic rationale for targeting LMP7 in autoimmune disorders. In this review we summarise the effect of immunoproteasome inhibition in animal models for rheumatoid arthritis, inflammatory bowel disease, Hashimoto’s thyroiditis, systemic lupus erythematosus, and multiple sclerosis.</dcterms:abstract> <void:sparqlEndpoint rdf:resource="http://localhost/fuseki/dspace/sparql"/> <dc:creator>Basler, Michael</dc:creator> <dc:contributor>Schmidt, Christian</dc:contributor> <dc:date rdf:datatype="http://www.w3.org/2001/XMLSchema#dateTime">2016-03-03T13:58:09Z</dc:date> <dcterms:title>The immunoproteasome : a novel drug target for autoimmune diseases</dcterms:title> <dc:contributor>Mundt, Sarah</dc:contributor> <dc:creator>Mundt, Sarah</dc:creator> <dcterms:isPartOf rdf:resource="https://kops.uni-konstanz.de/rdf/resource/123456789/28"/> <dspace:isPartOfCollection rdf:resource="https://kops.uni-konstanz.de/rdf/resource/123456789/28"/> <dc:creator>Schmidt, Christian</dc:creator> <dcterms:available rdf:datatype="http://www.w3.org/2001/XMLSchema#dateTime">2016-03-03T13:58:09Z</dcterms:available> <dc:contributor>Bitzer, Annegret</dc:contributor> <dc:language>eng</dc:language> <foaf:homepage rdf:resource="http://localhost:8080/jspui"/> <dc:contributor>Groettrup, Marcus</dc:contributor> </rdf:Description> </rdf:RDF>

This item appears in the following Collection(s)

Search KOPS


Browse

My Account